“Seeking a treatment for schizophrenia, scientists at the Munsterlingen asylum in Switzerland found that a drug that tweaked the balance of the brain's neurotransmitters — the chemicals that control mood, pain and other sensations, so that sent patients into bouts of euphoria. For schizophrenics, of course, that only made their condition worse. But researchers soon acknowledge that it made the pill perfect for patients with depression.” On first trying it in 1955, some patients found that the newly sociable and energetic and called the drug a "miracle cure." The drug was a major success. In 1987 scientist predicted the “miracle cure” could earn its parent, Eli Lilly & Co., up to $175 million a year by 1990. It blew past that target in 1989, earning $350 million — more than had been spent annually on all antidepressants put together just two years previously. By 1990, “miracle cure” was the country's most prescribed antidepressant, with 650,000 scrips written or renewed each month. Annual sales soon topped $1 billion. However, in multiple occasions drugs that were supposed to help the brain can be used for the wrong
“Seeking a treatment for schizophrenia, scientists at the Munsterlingen asylum in Switzerland found that a drug that tweaked the balance of the brain's neurotransmitters — the chemicals that control mood, pain and other sensations, so that sent patients into bouts of euphoria. For schizophrenics, of course, that only made their condition worse. But researchers soon acknowledge that it made the pill perfect for patients with depression.” On first trying it in 1955, some patients found that the newly sociable and energetic and called the drug a "miracle cure." The drug was a major success. In 1987 scientist predicted the “miracle cure” could earn its parent, Eli Lilly & Co., up to $175 million a year by 1990. It blew past that target in 1989, earning $350 million — more than had been spent annually on all antidepressants put together just two years previously. By 1990, “miracle cure” was the country's most prescribed antidepressant, with 650,000 scrips written or renewed each month. Annual sales soon topped $1 billion. However, in multiple occasions drugs that were supposed to help the brain can be used for the wrong